Momentum will be holding its 2nd Congress on PIV Litigation on October 29-30, 2014 in Philadelphia, PA. The conference will offer presentations on the following topics:
• Key Takeaways for Brand and Generic Drug Manufacturers from Recent Case Law
• Are Your Ducks in a Row? -- Examining the Top 3 Pre-Suit Due Diligence Issues Counsel on Both Sides Should Be Evaluating In Anticipation of a Paragraph IV Suit
• The Expansion of the Hatch Waxman Safe Harbor -- Addressing HOW Recent Developments in the Evolution of Case Law Are Impacting Litigation Approaches to Paragraph IV Disputes
• PTO v. Federal District Court -- Evaluating the Emerging Impact of Parallel PTO Proceedings on the Procedural Dynamics of Hatch Waxman Litigation
• Patent Reform -- What You Don't Know is In There -- A True Examination of Proposed Patent Legislation and the Impact Each Bill Could Have on the Pharmaceutical Industry and Related IP Litigation
• Insider Tips for Obtaining Successful Results When Engaged in a Paragraph IV Dispute in the District of Delaware -- Proven Strategies for Effectively Engaging with the Bench and Working with Local Counsel
• Insider Tips from the Bench on How to Most Effectively Present Experts and Witness during Paragraph IV Litigation
• Forfeiture and Multiple Filers -- Forfeiture and Multiple Filers: Insights for Avoiding or Triggering Forfeiture Events in Hatch-Waxman Litigation Involving Multiple ANDA Filers
• Spotlight Address -- Perspectives from the FTC on Pay-for-Delay Settlements
• Paragraph IV Settlements Post-Actavis -- Can They Be Done and If So, How? -- Live Mock Negotiation
• Communication with Key Stakeholders -- Litigation Communication Strategies for In-House Counsel When Actively Engaged in a Paragraph IV Dispute
• When Prior Settlements Come Back To Haunt You -- What Brand Name and Generic Drug Manufacturers Can Learn from Recent Third Party Payor Suits Challenging the Implications of Hatch Waxman Litigation on Drug Competition
In addition, two interactive working group sessions will be offered during the conference. The first workshop is entitled "PTEs, Combination Products and 'Product Hopping': Life Cycle Management Insights for Brand Name Drug Manufacturers Engaged in Paragraph IV Litigation," and the second is entitled "At Risk Launches: An Examination of the Business Benefits and Legal Risks of Launching at Risk -- How to Determine If It’s Truly Worth It . . . or Not Making the decision to launch a product 'at risk' is one that can bring with it great financial."
The agenda for the International Congress on Paragraph IV Litigation can be found here.
The registration fee for the conference is $1,395 (in-house/corporate), $1,795 (private practice), or $1,95 (all other companies). Those interested in registering for the conference can do so here.
Patent Docs is a media partner of Momentum's Congress on PIV Litigation.
Photograph of Independence Hall (above) by Dan Smith, from the Wikipedia Commons under the Creative Commons license.
Comments